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 37 
Structured Summary 38 
Objective: To report prevalence, risk factors and clinical outcomes for presumptive 39 
gastric dilation-volvulus diagnosed among an emergency-care population of UK dogs. 40 
Methods: Cross-sectional study design using emergency-care veterinary clinical records 41 
from the VetCompassTM Programme spanning September 1st, 2012 to February 28th, 42 
2014. Risk factor analysis using multivariable logistic regression modelling.  43 
Results: The study population comprised 77,088 dogs attending 50 Vets Now clinics. 44 
Overall, 492 dogs had presumptive gastric dilation-volvulus diagnoses giving a 45 
prevalence of 0.64% (95%CI: 0.58% - 0.70%). Compared with crossbred dogs, breeds 46 
with the highest odds ratios for diagnosis of presumptive gastric dilation-volvulus were 47 
the great Dane (OR: 114.3, 95% CI 55.1-237.1, P < 0.001), akita (OR: 84.4, 95% CI 48 
33.6-211.9, P < 0.001) and dogue de Bordeaux (OR: 82.9, 95% CI 39.0-176.3, P < 49 
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0.001). Odds increased as dogs aged up to 12 years and neutered male dogs had 1.3 50 
(95% CI 1.0-1.8, P = 0.041) times the odds compared with entire females. Of 51 
presumptive gastric dilation-volvulus cases that presented alive, 49.7% survived to 52 
discharge but 79.3% of surgical cases survived to discharge.  53 
Clinical importance: Approximately 80% of surgically managed cases survived to 54 
discharge. Certain large breeds were highly predisposed.  55 
 56 
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 59 
Abbreviations 60 
CI – confidence interval 61 
EPR – electronic practice record 62 
GDV – gastric dilation-volvulus 63 
IQR – interquartile range 64 
OR – odds ratio 65 
RVC - Royal Veterinary College 66 
SD - standard deviation 67 
 68 
Introduction 69 
Gastric dilation-volvulus (GDV) is generally an acute and life-threatening condition with 70 
severe multi-systemic effects in dogs (Brockman 2012, Sharp and Rozanski 2014). The 71 
precise pathophysiology of GDV is unclear but the presentation is characterised by rapid 72 
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accumulation of various combinations of gas, fluid and ingesta in the stomach, with 73 
increased intra-gastric pressure (Hendriks and others 2011). Dilation of the stomach and 74 
rotational twist along its horizontal axis compress the major abdominal blood vessels and 75 
impair venous return to the heart, leading to impaired cardiac output and shock 76 
(Glickman and others 1994). If left untreated, severe systemic hypoperfusion can ensue 77 
via multiple mechanisms (hypovolaemic, distributive and obstructive shock) along with 78 
additional respiratory compromise and decreased tidal volume that results from 79 
restriction of diaphragmatic excursions by the enlarged stomach (Monnet 2003). 80 
Diagnosis is commonly based on a combination of characteristic historical and physical 81 
examination findings (notably abdominal distension and pain, tachycardia, poor 82 
peripheral pulses and unproductive retching), combined with evidence of gastric 83 
malpositioning and enlargement apparent from diagnostic imaging (Tivers and Brockman 84 
2009).  85 
A typical combination of significant pain and a high mortality rate make GDV both a 86 
clinical and welfare concern in affected dogs. Among UK pedigree dogs participating in a 87 
survey-based retrospective study, GDV was reported to cause 2.5% of all deaths, with a 88 
median age at death of 7.9 years (Evans 2010). A US study of large and giant dog 89 
breeds reported that 16% of deaths in these breeds were from GDV (Glickman and 90 
others 2000) and that 28.6% of GDV cases died directly from the disorder (Glickman 91 
2000).  92 
GDV is a complex disorder with multiple interacting inherited and environmental factors 93 
reported to affect the probability of a GDV event (Bell 2014). Reported prevalence values 94 
for GDV in dogs varies widely across differing breeds and populations but it is generally 95 
recognised as a disorder that mainly affects large and giant breeds (Glickman and others 96 
1994). Purebred dogs are reported to be predisposed to GDV compared with crossbred 97 
dogs, with reported odds ratios (OR) ranging from 1.8 (95% confidence interval [CI] 98 
1.1-2.9) (Bellumori and others 2013) to 2.5 (95% CI 2.1-3.0) (Glickman and others 99 
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1994). Larger body size (Glickman and others 1994, Glickman and others 2000) and 100 
deep-chested conformations (Bell 2014) have been reported as risk factors for GDV. 101 
Many breeds are reported as predisposed to GDV, and these include great Dane, 102 
bloodhound, German shepherd, standard poodle, grand bleu de Gascogne, German 103 
pointer, akita, Irish setter, Weimaraner and Neapolitan mastiff (Bell 2014, Brockman 104 
1995, Evans 2010, Glickman 2000). Advancing age has also been reported to 105 
substantially increase risk of GDV (Elwood 1998, Glickman 2000, Theyse and others 106 
1998) but evidence to support a sex predisposition to GDV has been more equivocal 107 
(Eggertsdóttir and Moe 1995, Glickman and others 1997, Glickman and others 1994, 108 
Glickman and others 2000).  109 
Research using primary-care veterinary clinical records has been recommended as a 110 
means to generate reliable and generalisable information on the occurrence and risk 111 
factors for disorders affecting the wider animal population (O'Neill and others 2014a). 112 
This study aimed to analyse a database of merged emergency-care practice electronic 113 
patient records (EPRs) to estimate the prevalence of presumptive GDV diagnoses among 114 
an emergency-care caseload of dogs in the UK and to evaluate demographic risk factors 115 
for the occurrence of GDV. The study additionally aimed to report on clinical 116 
management and survival among this presumptive GDV caseload.To unpick the 117 
interacting effects of breed and body size, it was hypothesised that, within breeds, 118 
animals with bodyweight above their breed mean have an increased odds ratio of 119 
presumptive GDV diagnosis compared with those at or below the breed mean.  120 
 121 
Materials and methods 122 
The current study was part of the VetCompassTM Programme of research at the Royal 123 
Veterinary College (RVC)  (VetCompass 2017) and included all dogs attending Vets Now 124 
practices with at least one electronic patient record (EPR) recorded within the 125 
6 
 
VetCompassTM database from September 1st, 2012 to February 28th, 2014 (Vets Now 126 
2015). These dates were selected because they covered the span of available clinical 127 
records at the time of the study. Vets Now clinics use a standard practice management 128 
system called Helix and Vets Now team members are required to record presenting signs 129 
and encouraged to record diagnoses using the Venom Coding standardised terminology 130 
(The VeNom Coding Group 2017). A clinical query was used to extract EPR data from the 131 
Helix system that were then uploaded to a secure structured query language database 132 
(O'Neill and others 2014b). Data available for the current study included demographic 133 
(breed, date of birth, sex, neuter status, insurance status and bodyweight) and clinical 134 
(clinical notes, treatment, presenting signs and diagnosis terms with relevant dates) 135 
information.  136 
A cross-sectional analysis was used to estimate prevalence and evaluate associations 137 
between risk factors and GDV diagnosis. Based on the main study hypothesis, sample 138 
size calculation estimated that a cross-sectional study would require 5,148 dogs of 139 
below-average weight and 5,148 dogs of above-average weight to identify within-breed 140 
bodyweight as a risk factor with an odds ratio ≥ 2.0 (unexposed:exposed ratio 1:1, 95% 141 
confidence level, 80% power  and 0.5% of the unexposed animals with GDV) (Epi  Info 7 142 
CDC 2015). Ethics approval was granted by the RVC Ethics and Welfare Committee 143 
(reference number S25/2014).  144 
In this study, the case definition for diagnosis of GDV required that the dog was 145 
presented either dead or alive at a participating clinic and that a final diagnosis of GDV 146 
(or synonyms covering either torsion or volvulus) was recorded in the EPR based on first 147 
opinion emergency-care diagnostic criteria. Because not all cases underwent definitive 148 
diagnosis by radiography, surgery, or both, the diagnosis must be considered to be 149 
presumptive in some cases. However, dogs that were specified as having gastric dilation 150 
without volvulus did not meet the case definition for this study and were excluded. On 151 
the other hand, animals that were already dead at the time of first presentation and that 152 
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met the case definition were included because of the risk that overall prevalence and risk 153 
factor values might otherwise be biased by preferentially removing categories of dog 154 
with more acute presentations and that tended to die more rapidly.  155 
The case-finding process involved an initial EPR screening of all study dogs to identify 156 
potential GDV candidate cases by multiple searches of the clinical free-text (gdv, volvul, 157 
torsion, gastric dilat, bloat, twisted stom, gastropexy) and the VeNom term fields 158 
(Gastric (stomach) dilation, Gastric (stomach) torsion – chronic and Gastric dilation-159 
volvulus syndrome (GDV)). Candidate GDV cases were randomly sorted using the 'RAND' 160 
function in Microsoft Excel (Microsoft Office Excel 2007, Microsoft Corp.) to avoid 161 
temporal bias during review and the full clinical records were read manually by one of 162 
the authors (JC) before deciding on case inclusion and extracting clinical information 163 
following a standardised process. For included cases, any previous episodes of GDV were 164 
recorded and the date of diagnosis of the current presumptive GDV event were 165 
described. Additionally, the presenting status (ambulatory or collapsed), blood lactate 166 
concentration at presentation, surgical management (including whether a gastropexy or 167 
splenectomy was performed) and clinical outcome (dead on arrival, non-survival, 168 
survived) were reported. For the analysis, all dogs not meeting our GDV case definition 169 
were included as non-cases for presumptive GDV.  170 
Following data checking and cleaning in Excel using internal data validity evaluations 171 
(Microsoft Office Excel 2007, Microsoft Corp.), statistical analyses were conducted using 172 
Stata Version 11.2 (Stata Corporation). Prevalence values with 95% CI were reported 173 
overall and for individual common breeds. The 95% CI estimates were derived from 174 
standard errors based on approximation to the normal distribution (Kirkwood and Sterne 175 
2003). Descriptive statistics characterised purebred status, breed, sex/neuter, age, 176 
actual bodyweight and bodyweight relative to breed mean for the GDV case and non-case 177 
dogs separately. The breed variable included individual breeds with 10 or more 178 
presumptive GDV cases recorded, a group containing the remaining purebred dogs 179 
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('other purebred’) and a group containing the crossbreds. Actual bodyweight (kg) 180 
described the maximum recorded bodyweight for dogs of any age. Six actual-bodyweight 181 
categories were generated: (0.0-9.9, 10.0-19.9, 20.0-29.9, 30.0-39.9, ≥ 40.0 and no 182 
bodyweight recorded). The mean adult bodyweight was calculated for individual breeds 183 
using bodyweight data from dogs aged over 18 months and these values were used to 184 
categorise individual dogs aged over 18 months as being either above or at/below their 185 
breed mean value (‘bodyweight relative to breed mean’). Age (years) described the age 186 
at diagnosis for case animals and the age at the mid-point between the first and final EPR 187 
for the non-case animals. Age was categorised into six groups (< 3.0, 3.0-5.9, 6.0-8.9, 188 
9.0-11.9, ≥ 12.0 and not available). Analysis of age and bodyweight as categorical 189 
variables was planned during the study design because associations between these 190 
variables and clinical outcomes are rarely linear and therefore analysis as continuous 191 
variables is statistically inappropriate (Kirkwood and Sterne 2003, O'Neill and others 192 
2016, Taylor-Brown and others 2015). The additional categories that described missing 193 
data for the bodyweight and age variables were included in the analyses in order to 194 
better understand the impact that missing data may have had on the results for these 195 
variables. Blood lactate concentrations (mmol/L) were categorised into 5 groups (< 2, 2 196 
to < 4, 4 to < 6, 6 to < 8 and ≥ 8). These cut-offs were selected to be consistent with 197 
previously published results (Green and others 2011). Animals discharged alive from Vets 198 
Now clinical care were defined as having survived while those that died or were 199 
euthanased whilst still under the care of Vets Now were classified as non-surviving. 200 
Categorical variables were compared between groups using the chi-square test or Fishers 201 
exact test and quantitative variables were compared using the unpaired t-test or 202 
Wilcoxon rank sum test as appropriate (Kirkwood and Sterne 2003). A Bonferroni 203 
adjusted P–value of 0.007 was accepted for statistical significance to account for the 204 
effects of multiple testing (Aickin and Gensler 1996). 205 
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Binary logistic regression modelling was used to evaluate univariable risk factor 206 
associations with presumptive GDV occurrence. Purebred status (highly correlated with 207 
breed) and actual bodyweight (bodyweight was considered to be a defining characteristic 208 
of individual breeds) were excluded from multivariable modelling. Other factors with 209 
liberal associations in the univariable modelling (P < 0.2) were taken forward for 210 
multivariable evaluation. Model development used manual backwards stepwise 211 
elimination. Clinic attended was entered as a random effect to quantify the diagnostic 212 
variation for presumptive GDV between clinics (Bolker and others 2009). Such variation 213 
could result, for example, from regional geographic or breed associations with 214 
occurrence across the UK. Pair-wise interaction effects were evaluated for the final model 215 
variables (Dohoo and others 2009). The Hosmer-Lemeshow test statistic and the area 216 
under the ROC curve were used to evaluate model fit (non-random effect model) (Dohoo 217 
and others 2009). Statistical significance was set at P < 0.05 for the logistic regression 218 
modelling.  219 
 220 
Results 221 
Descriptive results: demography and clinical outcomes 222 
Data completeness overall differed widely between the variables: sex 82.5%, neuter 223 
82.5%, insurance 100.0%, date of birth 84.7%, actual bodyweight 33.4% and breed 224 
88.9%. The study population comprised 77,088 dogs attending 50 Vets Now clinics 225 
across the UK. There were 492 dogs that met our presumptive GDV diagnosis case 226 
definition, giving a prevalence of 0.64% (95% CI 0.58% - 0.70%) of the overall canine 227 
emergency-care caseload. The prevalence of presumptive GDV varied widely across the 228 
breeds. Breeds with the highest prevalence included great Dane (14.0% prevalence, 95% 229 
CI 9.8-19.1), akita (9.2%, 95% CI 4.5-16.2), dogue de Bordeaux (7.2%, 95% CI 4.6-230 
10.7), Irish setter (7.1%, 95% CI 3.7-12.1) and Weimaraner (7.1%, 95% CI 5.0-9.8). 231 
The prevalence among crossbreds was 0.1% (0.1-0.2) (Table 1). 232 
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Of the presumptive GDV dogs with information available, 431 (96.2 %) were purebred, 233 
167 (40.2%) were female, 85 (17.3%) were insured and 168 (40.5%) were neutered 234 
(Table 2). The median actual bodyweight was 38.8 kg (IQR: 30.0 – 48.5, range: 3.7 – 235 
87.0) and the median age was 8.0 years (IQR: 6.0 – 10.0, range:  0.3 – 20.0) (Figure 236 
1). The most common 11 breeds accounted for 264 (53.7%) of the case dogs. Eleven 237 
breeds had 10 or more affected individuals recorded: akita, boxer, dogue de Bordeaux, 238 
great Dane, basset hound, Dobermann pinscher, Labrador retriever, Rhodesian 239 
ridgeback, Irish setter, German shepherd dog and Weimaraner. Of these, the highest 240 
breed prevalence was recorded for the great Dane (14.0%, 95% CI 9.8-19.1) and akita 241 
(9.2%, 95% CI 4.5-16.2) (Table 2). Data completeness for the presumptive GDV cases 242 
was: sex 84.3%, neuter 84.3%, insurance 100.0%, date of birth 90.7%, actual 243 
bodyweight 37.8% and breed 91.1%. 244 
 245 
Of the non-case dogs with information available, 55,676 (81.8%) were purebred, 30,046 246 
(47.5%) were female, 11,854 (15.5%) were insured and 22,690 (35.9%) were neutered. 247 
The median bodyweight of non-case dogs was 14.7 kg (IQR: 7.8-25.7, range: 0.2 – 248 
100.0) and the median age was 5.0 years (IQR: 1.7 – 10.0, range:  0.0 – 25.0) (Table 249 
2). The most common breed types in the overall study were Labrador retriever (9.8%), 250 
Jack Russell terrier (5.5%), Staffordshire bull terrier (4.3%) and cocker spaniel (4.1%). 251 
Data completeness for the non-cases was: sex 82.5%, neuter 82.5%, insurance 100.0%, 252 
date of birth 84.6%, actual bodyweight 33.4% and breed 88.9%. 253 
Nine of the 492 presumptive GDV cases overall (1.8%) presented as ‘dead on arrival’. Of 254 
the dogs that were alive at presentation, 243/483 (50.3%) did not survive to discharge, 255 
with 215 (88.5%) of these deaths involving euthanasia. Of the 198 dogs that were alive 256 
at presentation and did not undergo surgery, 184 (92.9%) did not survive the 257 
emergency-care period, with the remaining 14 (7.1%) alive at discharge to their 258 
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primary-care practices or to their owners' care after which no further information was 259 
available. Of these 184 deaths, 178 (96.7%) were due to euthanasia and 6 (3.3%) were 260 
unassisted. Of the 285 dogs that underwent surgery, 226 (79.3%) survived and 59 261 
(20.7%) did not survive the emergency-care period. Of these 59 deaths, 37 (62.7%) 262 
were due to euthanasia and 22 (37.3%) were unassisted (Figure 2). Overall, 169/215 263 
(78.6%) presumptive GDV cases that were euthanased during the study period had 264 
information specified in the free-text notes describing the main reasons that the owner 265 
elected for euthanasia. Of these, 118 (69.8%) euthanasia decisions were taken to avoid 266 
further animal suffering and 51 (30.2%) were taken following financial concerns related 267 
to ongoing treatment.  268 
Of dogs that were alive at presentation, 309 of 388 (79.6 %) presumptive GDV cases 269 
with information available were ambulatory. Cases that were ambulatory at presentation 270 
were significantly more likely to survive to discharge than non-ambulatory cases 271 
(survival: 158 (51.1%) ambulatory versus 17 (21.0%) non-ambulatory, P < 0.001). 272 
Ambulatory cases were also significantly more likely to have surgery than non-273 
ambulatory cases (surgery: 189 (61.2%) ambulatory versus 27 (33.3%) non-274 
ambulatory, P < 0.001). Of 481 presumptive GDV cases alive at presentation with 275 
information available, 189 (39.3%) did not receive any diagnostic imaging, 267 (55.5%) 276 
received radiology alone, 5 (1.0%) received ultrasonography alone and 20 (4.1%) 277 
received both radiology and ultrasonography. Of the dogs presented alive but that did 278 
not receive surgery, 81 (41.1%) received diagnostic imaging. Dogs that received some 279 
form of diagnostic imaging were more likely to have surgery than dogs that did not 280 
receive diagnostic imaging (221 (72.3%) versus 73 (38.6%), P < 0.001). Blood lactate 281 
concentrations were recorded for 181 (36.8%) cases and showed a median of 3.5 (IQR 282 
2.3-6.3, range 0.6-18.3) mmol/L. Blood lactate concentrations at presentation 283 
(categorised data) were not associated with the likelihood of surgery (P = 0.227). Dogs 284 
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with blood lactate concentrations < 4 mmol/L had an increased probability of survival to 285 
discharge both overall (P < 0.001) and among the surgical cases (P < 0.001) (Table 3).  286 
Of the presumptive GDV cases that were alive at presentation with information available, 287 
182/398 (45.7%) had an orogastric tube inserted and 285/483 (59.0%) were surgically 288 
managed. Dogs that underwent surgery were younger than dogs that did not undergo 289 
surgery (mean (standard deviation (SD)) 7.0 (3.1) years versus 9.2 (3.3) years, P < 290 
0.001) but bodyweight was not associated with surgery (surgical cases: mean (SD) 40.3 291 
(15.2) kg versus non-surgical cases: 40.9 (15.6) kg, P = 0.845). Insured cases were 292 
more likely to receive surgery than uninsured cases (67/85 insured [78.8%] versus 293 
218/406 uninsured [53.7%] respectively, P < 0.001). Of surgical cases with information 294 
available that survived to discharge, 17.5% (25 of 143 dogs) had a recorded gastrotomy 295 
procedure, 97.0% (191 of 197 dogs) underwent a recorded gastropexy procedure and 296 
14.9% (20 of 134 dogs) underwent a recorded splenectomy procedure. Splenectomised 297 
and non-splenectomised surgical cases did not differ in their proportional survival: 20 298 
(71.4%) versus 114 (73.1%), P < 0.001. Information on the duration of general 299 
anaesthesia was available for 242 dogs. The median (IQR, range) duration of general 300 
anaesthesia was 90.0 (60.0-120.0, 0.0-300.0) minutes (Table 4). The differing counts of 301 
cases with procedural information available is explained by differing clarity of the notes 302 
recorded in the EPRs about the procedures performed. 303 
 304 
Risk factors for diagnosis of presumptive GDV  305 
Univariable logistic regression modelling identified six variables with liberally significant 306 
(P < 0.20) association with presumptive GDV diagnosis: purebred status, breed, actual 307 
bodyweight, bodyweight relative to breed mean, age and sex/neuter status. Although not 308 
included in multivariable modelling as explained above, the univariable results indicated 309 
that purebred dogs had 5.6 (95% CI 3.5-9.2, P < 0.001) times the odds of presumptive 310 
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GDV compared with crossbred dogs and that increasing actual bodyweight was strongly 311 
associated with increased odds of the diagnosis, with dogs weighing ≥ 40 kg showing 312 
148.7 (95% CI 54.5-406.0, P < 0.001) times the odds compared with dogs weighing < 313 
10.0 kg. No association was identified between insurance status and diagnosis of 314 
presumptive GDV (P = 0.272).  315 
The final multivariable model comprised three risk factors: breed, age and sex/neuter 316 
status but did not identify bodyweight relative to breed mean as a significant risk factor. 317 
The final model showed acceptable model-fit (Hosmer-Lemeshow test statistic: P = 318 
0.680) and good discrimination (area under the ROC curve: 0.843). The final model was 319 
not improved by inclusion of the clinic attended as a random effect (P = 0.095) and no 320 
biologically significant interactions were identified. After accounting for the effects of the 321 
other variables evaluated in the multivariable model, the individual breeds with the 322 
highest odds ratios for presumptive GDV diagnosis compared with crossbred dogs were 323 
the great Dane (OR: 114.3, 95% CI 55.1-237.1, P < 0.001), akita (OR: 84.4, 95% CI 324 
33.6-211.9, P < 0.001) and dogue de Bordeaux (OR: 82.9, 95% CI 39.0-176.3, P < 325 
0.001). The odds of diagnosis increased as dogs aged up to 12 years and then 326 
decreased. Compared with dogs aged < 3 years, dogs aged from 6 to < 9 years had 9.5 327 
(95% CI 6.1-14.8, P < 0.001) times, and dogs aged from 9 to < 12 years 10.0 (95% CI 328 
6.4-15.6, P < 0.001) times, the odds of presumptive GDV diagnosis. Neutered male dogs 329 
had 1.3 (95% CI 1.0-1.8, P = 0.041) times the odds of diagnosis compared with entire 330 
females (Table 5).  331 
 332 
Discussion  333 
To our knowledge, this is the most comprehensive epidemiologic study of presumptive 334 
GDV diagnoses relative to all veterinary emergency cases that has been published to 335 
date. This study highlights the relevance of presumptive GDV to the canine emergency 336 
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caseload, with a prevalence of 0.64% and an overall survival of under 50% of all cases. 337 
Of dogs that underwent surgery, approximately 80% survived to discharge from 338 
emergency care. Risk factors for diagnosis identified in this study included breed, age > 339 
3 years and sex. The great Dane, akita and dogue de Bordeaux breeds had the highest 340 
odds of presumptive GDV. Ambulatory status and blood lactate concentrations at initial 341 
presentation appeared to be useful survival indicators but their true association with 342 
survival may be confounded by their influence on euthanasia decision-making by 343 
veterinarians and owners (i.e. these factors may have been used in making the decision 344 
for euthanasia).  345 
The diagnostic processes used in the current study were typical of first opinion 346 
emergency-care clinicians and may differ from strict diagnostic criteria that might include 347 
right lateral radiography of the cranial abdomen, post-mortem or laparotomy to confirm 348 
the GDV diagnosis (Glickman and others 1998, Tivers and Brockman 2009, Zacher and 349 
others 2010). Because not all of the cases included in the current study met this full 350 
diagnostic definition before being assigned a GDV diagnosis, the cases included in the 351 
current study have been labelled as presumptive GDV cases.  352 
The results of the study did not support the hypothesis that, within breeds, animals with 353 
bodyweight above their breed mean have an increased odds ratio of presumptive GDV 354 
compared with those at or below the breed mean. Although some association was 355 
indicated in the univariable analysis, this effect was no longer significant after accounting 356 
for other confounding differences (e.g. sex) using multivariable modelling. 357 
The current study reported a presumptive GDV prevalence of 0.64% of the overall 358 
canine emergency-care caseload, which is in broad agreement with a study of UK 359 
pedigree dogs (n = 36,006) that reported a GDV prevalence of 0·7% (Evans 2010). A US 360 
study of referral cases (n = 27,254) reported a lower prevalence of GDV of 0.2% 361 
(Bellumori and others 2013). Another US study reported that 2.4% of large-breed dogs 362 
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and 2.7% of giant-breed dogs had at least one GDV episode annually (Glickman and 363 
others 2000). However, it is difficult to compare prevalence results between studies that 364 
have widely differing populations at risk.  365 
First-opinion veterinary clinical records can be a valuable resource for reliable and 366 
generalisable health information on the wider animal population (O'Neill and others 367 
2014a). Dogs affected by GDV require prompt management to prevent poor clinical and 368 
welfare outcomes and are therefore commonly presented as emergency-care cases to 369 
out-of-hours clinics (Brockman 2012). Consequently, analysis of combined clinical 370 
records from a large number of emergency-care clinics in the UK has potential to provide 371 
valuable insights into the epidemiology of GDV that are difficult to gain from other data 372 
resources. Emergency-care clinical records benefit from reduced recall and 373 
misclassification bias because of contemporaneous recording of health information by 374 
qualified professionals at the point of clinical care when and can be geographically 375 
representative when the contributing clinics span the entirety of the UK (Bateson 2010, 376 
McGreevy 2007, O'Neill and others 2014a). Electronic patient records also enable 377 
researchers to identify and include all diagnosed cases, regardless of their level of clinical 378 
work-up and management, and to explore the free-text clinical notes to answer 379 
contextual questions concerning aspects of welfare, presentation, diagnosis and 380 
management.   381 
Purebred status was not evaluated in the multivariable modelling because it was highly 382 
correlated with breed. However, based on the univariable analysis in the current study, 383 
purebred dogs had over five times the odds of presumptive GDV compared with 384 
crossbreds. This finding is consistent with US studies emanating from referral clinics that 385 
reported odds ratios for purebred predisposition of 1.8 (Bellumori and others 2013), 2.5 386 
(Glickman and others 1994) and 4.8 (de Battisti and others 2012). A purebred 387 
predisposition for GDV may indicate a genuine inheritable predisposition but, 388 
alternatively, could reflect differing body-size distributions between purebred and 389 
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crossbred dogs. Although the median bodyweight of purebred and crossbred dogs is quite 390 
similar, purebred dogs tend to have a greater proportion of dogs with extreme large and 391 
small body size (O'Neill and others 2013) and GDV has been reported to be strongly 392 
associated with large or giant breed body types (Evans 2010). 393 
After accounting for the other factors analysed, the breeds with the highest risk of 394 
presumptive GDV compared with crossbred dogs in the current study included great 395 
Dane (OR 114.3), akita (OR 84.4), dogue de Bordeaux (OR 82.9), Irish setter (OR 67.4) 396 
and Weimaraner (OR 50.8). A previous UK study additionally identified high GDV 397 
prevalence in the grand bleu de Gascogne, bloodhound and otterhound (Evans 2010) 398 
while US studies also reported high odds for Saint Bernard (Bellumori and others 2013, 399 
Brockman 1995, Glickman and others 1994). Many of these predisposed breeds are 400 
considered as ‘deep-chested’, with this description written into their breed standards 401 
(The Kennel Club 2014). This suggests an association between this conformation and 402 
GDV, thereby offering opportunities to reduce GDV hazard via prophylactic gastropexy 403 
(Ward and others 2003) or breed selection against extreme deep-chested conformation 404 
(Bell 2014).  405 
Large or giant breeds feature heavily  among the predisposed breeds for GDV (Bell 406 
2014). The current study did not include actual bodyweight in the multivariable analysis 407 
because the breed variable already somewhat accounted for bodyweight. However, the 408 
univariable results did support an association between increasing bodyweight and 409 
increased odds of presumptive GDV, with dogs weighing 30.0-39.9 kg having 38.5 times 410 
the odds compared with dogs weighting < 10.0 kg. Similar associations between 411 
increasing bodyweight and risk of GDV have been reported in US studies of referred GDV 412 
cases (Glickman 2000, Glickman and others 1994). However, it is worth noting for the 413 
current study, that bodyweight data were available for less than 40% of the study dogs 414 
and that these results may be confounded by breed and sex effects. Consequently, 415 
exploration in future studies that control for these factors is warranted. 416 
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Older dogs were identified at higher risk of presumptive GDV in the current study, with 417 
dogs aged between 9 and 12 years showing 10 times the odds of dogs aged under 3 418 
years. A previous study reported significantly increasing odds of GDV in Irish setters as 419 
dogs aged (Elwood 1998). The risk of GDV was reported to increase by approximately 420 
20% with each year of age in large and giant breeds in the US (Glickman and others 421 
2000) and the odds of GDV rose by 1.9 times for each year as great Danes in the 422 
Netherlands aged from 1 to 10 years old (Theyse and others 1998). Progressive 423 
stretching of the hepatogastric ligament with increasing age has been suggested as a 424 
pathogenic pathway for this increase GDV risk with aging (Hall and others 1995).  425 
The current study did identify some evidence of a male predisposition, consistent with 426 
the results of a small US study (Glickman and others 1997). However, other previous 427 
studies have failed to identify a sex predisposition (Glickman and others 1994, Glickman 428 
and others 2000). Sex associations may be confounded by bodyweight, neutering and 429 
other factors that complicate the interpretation of true sex effects.  430 
The current study identified that 50.3% of the emergency-care presumptive GDV 431 
caseload that presented alive did not survive to discharge, with 88.5% of these deaths 432 
involving euthanasia. This figure is very similar to the 86% of dog deaths that involve 433 
euthanasia under general primary veterinary care in the UK (O'Neill and others 2013). 434 
However, 79.3% of dogs that underwent surgery survived to discharge from emergency 435 
care. Although the relatively high survival rate for surgical cases may reflect effective 436 
case selection for surgical intervention, it is possible that many animals that did not 437 
receive surgery may also have survived if this option had been elected. There was a 438 
trend for breeds with a higher prevalence of presumptive GDV to be more likely to 439 
undergo surgery and therefore to have better overall survival (Table 2). This may reflect 440 
the probability that the owners of predisposed breeds are more aware of the disease in 441 
general and therefore better prepared to make the decision for surgical treatment during 442 
the emergency-care consultation at a time of extreme emotional distress.  443 
18 
 
It is difficult to compare the proportions of dogs undergoing surgery and their survival 444 
rates against previous publications because of differing study case definitions, case 445 
populations, methodologies and data sources between the published works. A study of 446 
working farm dogs in New Zealand reported 65% survival overall but the study included 447 
dogs affected with gastric dilation either with or without volvulus and included only dogs 448 
that received either radiography, surgery or post-mortem affected with GDV (Hendriks 449 
and others 2011). US studies of surgically-managed cases in referral clinic settings have 450 
reported survival rates of 90% (Mackenzie and others 2010), 88% (Green and others 451 
2011), 85% (Brockman 1995), 84% (Beck and others 2006) and 82% (Brourman and 452 
others 1996). The lower survival reported in the current study may reflect inclusion of 453 
more acute and severe cases in the first-opinion emergency-care setting and differing 454 
case management compared with the referral situation and suggests that the results of 455 
the current study may be more applicable to the wider canine population. In addition, 456 
many of the deaths in the current study involved euthanasia, and over 30% of these 457 
deaths were related to financial concerns, which may have biased the survival rates 458 
downwards. 459 
Taken at face value, the current findings might suggest that assessing ambulation and 460 
blood lactate concentrations at initial clinical presentation may be useful survival 461 
indicators for presumptive GDV. In the current study, 51.1% of dogs that were 462 
ambulatory at presentation survived compared with 21.0% survival in alive but non-463 
ambulatory dogs. Lower initial lactate concentrations were also associated with higher 464 
survival rates in the current study (Table 3). These findings are consistent with other 465 
reports that suggest the prognostic value of blood lactate estimation (Beer and others 466 
2012). Among surgical GDV cases in the US, the median initial plasma lactate 467 
concentration in dogs that survived was 3.4 mmol/L compared with 6.80 mmol/L for  468 
non-survivors (Green and others 2011). A US study of a general emergency caseload 469 
reported that 4.9% of patients with blood lactate concentrations up to 2.5 mmol/L died 470 
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compared with 28.4% of patients with lactate values at or above 4.0 mmol/L (Shapiro 471 
and others 2005). Among systemically ill dogs in Canada, dogs with lactate 472 
concentrations above 2.3 mmol/L had 16 times more risk of dying than dogs with lactate 473 
concentrations at or below 2.3 mmol/L (Stevenson and others 2007). However, it is 474 
likely that associations between ambulation and blood lactate concentrations with 475 
subsequent survival are highly complex and so it may be unsafe to draw definitive 476 
conclusions from the current study results because of possible reverse-causality effects.  477 
Non-ambulatory dogs or those with high blood lactate concentrations may have been 478 
considered a priori to have a poorer prognosis by the owner or the attending veterinary 479 
surgeon and thus have been more likely to be euthanased. . It should also be noted that 480 
data availability for ambulatory status (79.2%) and plasma lactate concentration 481 
(36.8%) were not complete and therefore some biases relating to missing data may 482 
have affected the results. Survival analyses where clinicians were blinded to the values 483 
of potential prognostic indicators are needed to more definitively clarify the predictability 484 
of ambulation and blood lactate concentration as useful clinical indicators for survival, 485 
especially when they may be applied to individual animals.         486 
Gastropexy, where the stomach is securely adhered to the abdominal wall, is clinically 487 
indicated in all dogs that undergo surgical correction of GDV to prevent recurrence (Allen 488 
and Paul 2014). GDV cases that receive gastropexy may have less than 5% recurrence 489 
and a median survival time of 547 days whereas those that do not receive gastropexy 490 
may have up to 80% recurrence and a median survival time of 188 days (Allen and Paul 491 
2014, Glickman and others 1998). In this current study 3% of the surgical cases did not 492 
have a gastropexy procedure recorded in their clinical notes and so it appears that 493 
gastropexy is widely accepted as a clinical standard in the UK.  494 
 495 
The current study had some limitations. Because of the urgent nature of emergency-care 496 
presentations and because these data were not recorded primarily for research 497 
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purposes, many of the available data fields in the clinical records were incomplete or 498 
missing and it cannot be assumed that these data were missing at random. 499 
Consequently, ‘missingness’ may have introduced some bias into the final results and 500 
categories that described missing data were included in the analyses to try to quantify 501 
such biases. The EPRs of emergency-care patients described mainly the current 502 
presentation and often provided very limited information on prior history. Dogs were 503 
generally lost to longer-term follow-up after the immediate emergency-care treatment 504 
period. Serial blood lactate concentrations values were not available for this study. This 505 
study reports the prevalence of presumptive GDV within the first-opinion emergency-506 
care population and the management and outcomes of these cases may not be fully 507 
representative of the wider dog population (Bartlett and others 2010). However, these 508 
differences should have less impact on the generalisability of results from the risk factors 509 
which are more dependent on basic physiology and therefore should be more constant 510 
across all dogs in the UK (Elwood 2007).    511 
 512 
Conclusion 513 
These results provide a baseline against which future studies of GDV in the UK primary-514 
care population can be judged and provide information that may help to inform both 515 









Figure 1: Age at diagnosis of presumed gastric dilation-volvulus in 466 dogs attending 523 





Figure 2: Flowchart showing some outcomes for presumed gastric dilation-volvulus in 527 






























Crossbreed 10,713 12 0.1 0.1-0.2 4 (33.3) 1 (25.0) 9 (75.0) 
Great Dane 236 33 14.0 
9.8-
19.1 
24 (72.7) 3 (12.5) 12 (36.4) 
Akita 109 10 9.2 
4.5-
16.2 
4 (40.0) 0 (0.0) 6 (60.0) 
Dogue de 
Bordeaux 
318 23 7.2 
4.6-
10.7 
9 (39.1) 2 (22.2) 16 (69.6) 
Irish Setter 169 12 7.1 
3.7-
12.1 
10 (83.3) 1 (10.0) 3 (25.0) 
Weimaraner 480 34 7.1 5.0-9.8 21 (61.8) 6 (28.6) 17 (50.0) 
Rhodesian 
Ridgeback 
194 10 5.2 2.5-9.3 
8 (80.0) 3 (37.5) 5 (50.0) 
Basset Hound  241 11 4.6 2.3-8.0 7 (63.6) 1 (14.3) 5 (45.5) 
German 
Shepherd Dog 
1,910 74 3.9 3.1-4.8 
41 (55.4) 10 (24.4) 42 (56.8) 
Dobermann 
Pinscher 
417 12 2.9 1.5-5.0 
5 (45.5) 1 (20.0) 8 (66.7) 
Boxer 1,308 23 1.8 1.1-2.6 8 (34.8) 3 (37.5) 17 (73.9) 
Labrador 
Retriever 
6,707 22 0.3 0.2-0.5 
10 (45.5) 2 (20.0) 13 (59.1) 
Other 
purebreds 
54,264 216 0.4 0.3-0.5 
134 
(62.0) 
26 (19.4) 100 (46.3) 
Table 1: Prevalence with 95% confidence intervals (95% CI) for dog breed types 532 
commonly diagnosed with presumed gastric dilation-volvulus at first opinion emergency-533 



















Crossbred  17 (3.4) 12,377 (18.2) Base   
 Purebred 431 (96.2) 55,676 (81.8) 5.6 3.5-9.2 < 0.001 
Breed Crossbreed 12 (2.4) 10,701 (14.0) Base   
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Bordeaux 









































216 (43.9) 54,048 (70.6) 3.6 2.0-6.4 < 0.001 
 Labrador 
Retriever 





< 10.0 4 (0.8) 9,021 (11.8) Base   
 10.0-19.9 5 (1.0) 6,856 (9.0) 1.7 0.4-6.1 0.458 












 No recorded 
bodyweight 











Lower/Equal 70 (14.2) 8,989 (11.7) Base   
 Higher 85 (17.3) 7,644 (10.0) 1.4 1.0-2.0 0.028 




< 3.0 31 (6.3) 22,030 (28.8) Base   
 3.0 - 5.9 85 (17.3) 12,593 (16.4) 4.8 3.2-7.2 < 0.001 








 ≥ 12.0 66 (13.4) 10,741 (14.0) 4.4 2.8-6.7 < 0.001 
 No age data 
available 
26 (5.3) 11,776 (15.4) 1.6 0.9-2.6 0.091 
Sex/neuter  Female entire 100 (24.1) 18,609 (29.4) Base   
 Female 
neutered 
67 (16.1) 11,437 (18.1) 1.1 0.8-1.5 0.586 
 Male entire 147 (35.4) 21,917 (34.7) 1.2 1.0-1.6 0.088 
 Male neutered 101 (24.3) 11,253 (17.8) 1.7 1.3-2.2 <0.001 
Insurance  Non-insured 407 (82.7) 64,742 (84.5) Base   
 Insured 85 (17.3) 11,854 (15.5) 1.1 0.9-1.4 0.272 
Table 2: Descriptive and univariable logistic regression results for risk factors associated 539 
with a diagnosis of presumed gastric dilation-volvulus in dogs attending first opinion 540 
























No. (%)  
< 2 32 (17.7) 2 (6.2) 30 (93.8) 30 (93.8) 29 (96.7) 
2 to < 4 67 (37.0) 7 (10.4) 60 (89.6) 56 (83.6) 52 (86.7) 
4 to < 6 29 (16.0) 4 (13.8) 25 (86.2) 16 (55.2) 16 (64.0) 
6 to < 8 22 (12.2) 5 (22.7) 17 (77.3) 13 (59.1) 12 (70.6) 
≥ 8 31 (17.1) 7 (22.6) 24 (77.4) 10 (32.3) 10 (41.7) 
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Overall 181 (100.0) 25 (13.8) 156 (86.2) 125 (69.1) 119 (76.3) 
Table 3: Initial blood lactate concentration (mmol/L) and associations with surgery and 544 
survival to discharge in dogs alive at presentation that were diagnosed with presumptive 545 
gastric dilation-volvulus attending first opinion emergency-care veterinary practices in 546 















No. (%)  died or 
were 
euthanased 
No. (%)  
survived to 
discharge 
< 50 8 (42.1) 11 (57.9) 13 (68.4) 6 (31.6) 
50 - <100  3 (2.9) 100 (97.1) 25 (24.3) 78 (75.7) 
100 - <150 0 (0.0) 77 (100.0) 15 (19.5) 62 (80.5) 
≥ 150 0 (0.0) 43 (100.0) 8 (18.6) 35 (81.4) 
Overall 11 (4.5) 231 (95.5) 61 (25.2) 181 (74.8) 
Table 4: Duration of general anaesthesia (minutes) and associations with surgery and 552 
survival to discharge in dogs diagnosed with presumptive gastric dilation-volvulus 553 




Variable Category Odds ratio 95% CI* 
P-
Value 
Breed Crossbreed Base   
 Great Dane 114.3 55.1-237.1 < 0.001 
 Akita 84.4 33.6-211.9 < 0.001 
 Dogue de Bordeaux 82.9 39.0-176.3 < 0.001 
 Irish Setter 67.4 28.9-157.2 < 0.001 
 Weimaraner 50.8 25.2-102.7 < 0.001 
 Basset Hound  39.5 16.8-92.7 < 0.001 
 Rhodesian Ridgeback 31.0 12.2-78.6 < 0.001 
 German Shepherd Dog 27.5 14.4-52.4 < 0.001 
26 
 
 Dobermann Pinscher 20.8 8.7-49.5 < 0.001 
 Boxer 13.4 6.5-27.9 < 0.001 
 Labrador Retriever 2.4 1.2-5.1 0.019 
 Other purebreds 3.2 1.7-5.8 < 0.001 
Age category 
(years) 
< 3.0 Base   
 3.0 - 5.9 5.2 3.3-8.3 < 0.001 
 6.0 - 8.9 9.5 6.1-14.8 < 0.001 
 9.0 - 11.9 10.0 6.4-15.6 < 0.001 
 ≥ 12.0 5.6 3.4-9.2 < 0.001 
 No age data available 1.6 0.9-3.0 0.111 
Sex/neuter  Female entire Base   
 Female neutered 0.8 0.6-1.1 0.271 
 Male entire 1.2 0.9-1.6 0.168 
 Male neutered 1.3 1.0-1.8 0.041 
Table 5: Final multivariable logistic regression model for risk factors associated with a 558 
diagnosis of presumptive gastric dilation-volvulus in dogs attending first opinion 559 
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